$CPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATALYST PHARMACEUTICALS, INC.. Get notifications about new insider transactions in CATALYST PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 3.42 | 275,000 | 940,500 | 1,590,000 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 3.42 | 400,000 | 1,368,000 | 3,551,667 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 3.42 | 200,000 | 684,000 | 1,071,334 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 3.42 | 250,000 | 855,000 | 1,491,334 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Elsbernd Brian | Chief Compliance/Le ... | Option Exercise | A | 3.42 | 200,000 | 684,000 | 801,334 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Del Carmen Jeffrey | Chief Commercial Of ... | Option Exercise | A | 3.42 | 200,000 | 684,000 | 600,000 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
Jan 04 2021 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 3.42 | 30,000 | 102,600 | 356,167 | |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | M | 0.00 | 14,666 | 0 | 871,334 | |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Sell | S | 3.45 | 3,668 | 12,644 | 10,998 | 14.7 K to 11 K (-25.01 %) |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Buy | M | 0.00 | 14,666 | 0 | 14,666 | 0 to 14.7 K |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | M | 0.00 | 14,666 | 0 | 871,334 | |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Sell | S | 3.45 | 3,668 | 12,644 | 10,998 | 14.7 K to 11 K (-25.01 %) |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Buy | M | 0.00 | 14,666 | 0 | 14,666 | 0 to 14.7 K |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 0.00 | 30,833 | 0 | 3,151,667 | |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Payment of Exercise | F | 0.00 | 7,507 | 0 | 4,811,019 | 4.8 M to 4.8 M (-0.16 %) |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 0.00 | 30,833 | 0 | 4,818,526 | 4.8 M to 4.8 M (+0.64 %) |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 1,315,000 | |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Buy | M | 0.00 | 20,000 | 0 | 677,687 | 657.7 K to 677.7 K (+3.04 %) |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | M | 0.00 | 1,333 | 0 | 326,167 | |
Dec 28 2020 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Buy | M | 0.00 | 1,333 | 0 | 1,333 | 0 to 1.3 K |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | M | 0.00 | 14,666 | 0 | 1,241,334 | |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Payment of Exercise | F | 0.00 | 3,571 | 0 | 407,441 | 411 K to 407.4 K (-0.87 %) |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Buy | M | 0.00 | 14,666 | 0 | 411,012 | 396.3 K to 411 K (+3.70 %) |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | M | 0.00 | 1,333 | 0 | 326,167 | |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | M | 0.00 | 1,333 | 0 | 226,333 | 225 K to 226.3 K (+0.59 %) |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | Elsbernd Brian | Chief Compliance/Le ... | Option Exercise | A | 0.00 | 14,666 | 0 | 601,334 | |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | Elsbernd Brian | Chief Compliance/Le ... | Buy | M | 0.00 | 14,666 | 0 | 14,666 | 0 to 14.7 K |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | M | 0.00 | 1,333 | 0 | 326,167 | |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Buy | M | 0.00 | 1,333 | 0 | 306,874 | 305.5 K to 306.9 K (+0.44 %) |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | M | 0.00 | 1,333 | 0 | 326,167 | |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | M | 0.00 | 1,333 | 0 | 561,709 | 560.4 K to 561.7 K (+0.24 %) |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 0.00 | 1,333 | 0 | 326,167 | |
Dec 23 2020 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | M | 0.00 | 1,333 | 0 | 216,760 | 215.4 K to 216.8 K (+0.62 %) |
Sep 30 2020 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.99 | 7,000 | 20,930 | 560,376 | 553.4 K to 560.4 K (+1.26 %) |
Sep 30 2020 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.97 | 15,000 | 44,550 | 4,787,693 | 4.8 M to 4.8 M (+0.31 %) |
Dec 06 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | M | 2.53 | 150,000 | 379,500 | 886,000 | |
Dec 06 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Sell | S | 4.82 | 150,000 | 723,150 | 0 | 150 K to 0 (-100.00 %) |
Dec 06 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Buy | M | 2.53 | 150,000 | 379,500 | 150,000 | 0 to 150 K |
Dec 06 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | M | 2.53 | 150,000 | 379,500 | 886,000 | |
Dec 06 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Sell | S | 4.82 | 150,000 | 723,150 | 0 | 150 K to 0 (-100.00 %) |
Dec 06 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Buy | M | 2.53 | 150,000 | 379,500 | 150,000 | 0 to 150 K |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 0.00 | 60,000 | 0 | 1,335,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 4.64 | 180,000 | 835,200 | 1,275,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 327,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 4.64 | 33,500 | 155,440 | 323,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.00 | 92,500 | 0 | 3,182,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 4.64 | 740,000 | 3,433,600 | 3,090,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 327,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 4.64 | 33,500 | 155,440 | 323,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 327,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 4.64 | 33,500 | 155,440 | 323,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 0.00 | 44,000 | 0 | 1,036,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 4.64 | 132,000 | 612,480 | 992,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 327,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 4.64 | 33,500 | 155,440 | 323,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 327,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 4.64 | 33,500 | 155,440 | 323,500 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 0.00 | 44,000 | 0 | 691,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 4.64 | 132,000 | 612,480 | 647,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | Elsbernd Brian | Chief Compliance/Le ... | Option Exercise | A | 0.00 | 44,000 | 0 | 616,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | Elsbernd Brian | Chief Compliance/Le ... | Option Exercise | A | 4.64 | 132,000 | 612,480 | 572,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 0.00 | 44,000 | 0 | 1,256,000 | |
Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 4.64 | 132,000 | 612,480 | 1,212,000 | |
Nov 27 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | M | 1.13 | 100,000 | 113,000 | 860,000 | |
Nov 27 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Sell | S | 4.66 | 100,000 | 466,000 | 0 | 100 K to 0 (-100.00 %) |
Nov 27 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Buy | M | 1.13 | 100,000 | 113,000 | 100,000 | 0 to 100 K |
Nov 22 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | M | 0.79 | 100,000 | 79,000 | 960,000 | |
Nov 22 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Sell | S | 4.50 | 100,000 | 449,800 | 0 | 100 K to 0 (-100.00 %) |
Nov 22 2019 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Buy | M | 0.79 | 100,000 | 79,000 | 100,000 | 0 to 100 K |
Oct 11 2019 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 4.70 | 10,000 | 46,950 | 553,376 | 543.4 K to 553.4 K (+1.84 %) |
Oct 03 2019 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 4.89 | 10,000 | 48,900 | 4,772,693 | 4.8 M to 4.8 M (+0.21 %) |
Jun 11 2019 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 3.23 | 25,000 | 80,750 | 4,762,693 | 4.7 M to 4.8 M (+0.53 %) |
Dec 28 2018 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | P | 1.91 | 25,000 | 47,750 | 225,000 | 200 K to 225 K (+12.50 %) |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 1,095,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 1,020,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 945,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 290,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 265,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 290,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 265,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 2.24 | 166,667 | 373,334 | 2,350,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 2.24 | 166,667 | 373,334 | 2,183,333 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 2.24 | 166,666 | 373,332 | 2,016,666 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 1,060,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 985,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 910,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 290,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 265,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 290,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 265,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 2.24 | 38,334 | 85,868 | 515,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 2.24 | 38,333 | 85,866 | 476,666 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 2.24 | 38,333 | 85,866 | 438,333 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 290,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 2.24 | 25,000 | 56,000 | 265,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 1,080,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 1,005,000 | |
Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 930,000 | |
Dec 19 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.24 | 20,000 | 44,800 | 4,737,693 | 4.7 M to 4.7 M (+0.42 %) |
Dec 17 2018 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | P | 2.48 | 60,000 | 148,800 | 200,000 | 140 K to 200 K (+42.86 %) |
Dec 14 2018 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.50 | 20,000 | 50,000 | 543,376 | 523.4 K to 543.4 K (+3.82 %) |
Jun 11 2018 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | P | 3.41 | 20,000 | 68,200 | 140,000 | 120 K to 140 K (+16.67 %) |
Jun 08 2018 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 3.35 | 1,000 | 3,352 | 523,376 | 522.4 K to 523.4 K (+0.19 %) |
Jun 07 2018 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 3.31 | 4,000 | 13,222 | 522,376 | 518.4 K to 522.4 K (+0.77 %) |
Jun 01 2018 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 3.74 | 5,000 | 18,680 | 518,376 | 513.4 K to 518.4 K (+0.97 %) |
May 31 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 3.54 | 166,667 | 590,001 | 1,850,000 | |
May 31 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 3.54 | 166,667 | 590,001 | 1,683,333 | |
May 31 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 3.54 | 166,666 | 589,998 | 1,516,666 | |
May 31 2018 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | P | 3.75 | 20,000 | 75,000 | 120,000 | 100 K to 120 K (+20.00 %) |
Apr 03 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.29 | 20,000 | 45,800 | 4,717,693 | 4.7 M to 4.7 M (+0.43 %) |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 240,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 220,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 240,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 220,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 4.01 | 95,000 | 380,950 | 870,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 4.01 | 95,000 | 380,950 | 775,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 4.01 | 95,000 | 380,950 | 680,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 4.01 | 100,000 | 401,000 | 1,350,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 4.01 | 100,000 | 401,000 | 1,250,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 4.01 | 100,000 | 401,000 | 1,150,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 4.01 | 95,000 | 380,950 | 835,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 4.01 | 95,000 | 380,950 | 740,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 4.01 | 95,000 | 380,950 | 645,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 4.01 | 95,000 | 380,950 | 855,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 4.01 | 95,000 | 380,950 | 760,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 4.01 | 95,000 | 380,950 | 665,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 240,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 220,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 240,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 220,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 240,000 | |
Jan 04 2018 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 4.01 | 20,000 | 80,200 | 220,000 | |
Nov 17 2017 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | M | 0.47 | 50,000 | 23,500 | 145,000 | |
Nov 17 2017 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | M | 0.47 | 50,000 | 23,500 | 513,376 | 463.4 K to 513.4 K (+10.79 %) |
Nov 14 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 0.00 | 26,667 | 0 | 0 | |
Nov 14 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 0.00 | 26,667 | 0 | 4,697,693 | 4.7 M to 4.7 M (+0.57 %) |
Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | M | 0.47 | 50,000 | 23,500 | 145,000 | |
Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Payment of Exercise | F | 0.00 | 7,860 | 0 | 215,427 | 223.3 K to 215.4 K (-3.52 %) |
Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | M | 0.47 | 50,000 | 23,500 | 223,287 | 173.3 K to 223.3 K (+28.85 %) |
Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | M | 0.47 | 50,000 | 23,500 | 145,000 | |
Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Payment of Exercise | F | 0.00 | 7,860 | 0 | 305,541 | 313.4 K to 305.5 K (-2.51 %) |
Nov 13 2017 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Buy | M | 0.47 | 50,000 | 23,500 | 313,401 | 263.4 K to 313.4 K (+18.98 %) |
Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 0.47 | 200,000 | 94,000 | 500,000 | |
Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 0.47 | 200,000 | 94,000 | 4,671,026 | 4.5 M to 4.7 M (+4.47 %) |
Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | M | 0.47 | 200,000 | 94,000 | 285,000 | |
Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Buy | M | 0.47 | 200,000 | 94,000 | 657,687 | 457.7 K to 657.7 K (+43.70 %) |